Bio-Techne
Highly Engaged Employees
Business Services · Minnesota, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
614 Mckinley Pl NE, Minneapolis, Minneso...Phone Number
(612) 379-2956Website
www.bio-techne.comRevenue
$1.2 BillionStock Symbol
TECHIndustry
About Bio-Techne
Bio-Techne Org Chart
Is Bio-Techne your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Bio-Techne, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Bio-Techne is spiking on competitors!
Earning: See what the market has to say on Bio-Techne recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Bio-Techne launches new products
Check if Bio-Techne has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Bio-Techne has new funding data
Click to see if Bio-Techne had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Bio-Techne
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Bio-Techne
Compare insights from companies similar to Bio-Techne, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bio-Techne
Company Profile Activity
Activity Insights
Bio-Techne is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bio-Techne is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bio-Techne.
Bio-Techne Tech Stack
A closer look at the technologies used by Bio-Techne
Most Recent Scoops
Bio-Techne News & Media
Baron Asset Fund Sold Bio-Techne Corporation (TECH) Due to Concerns Over Potential Impact of AI
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Asset Fund”. A copy of the letter is available to download here. U.S. equity markets started the year on a positive note. In February, market dynamics changed due to concerns about AI disruption, accelerated by U.S. and Israeli military action in […]Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Bio-Techne Corporation (TECH) Bank of America Global Healthcare Conference 2026 May 12, 2026 12:20 PM EDTCompany ParticipantsKim Kelderman - CEO, President...Bio-Techne Declares Dividend
MINNEAPOLIS, May 6, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2026. The quarterly dividend will be payable May 29, 2026, to all common shareholders of...Bio-Techne Releases Third Quarter Fiscal 2026 Results
MINNEAPOLIS, May 6, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2026. Third Quarter FY2026 Highlights Reported and organic revenue declined 2% to $311.4M, negatively impacted by prior‑year GMP...
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bio-Techne
Founded in 1981, Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and prov... Read More

